NAMS — NewAmsterdam Pharma NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for NewAmsterdam Pharma NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	IFRS	IFRS	USG	USG	USG
Status:	fx Final	fx Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9.6	60.4	468	340	834
Net Total Receivables	0	4.88	2.07	1.88	21.3
Prepaid Expenses
Total Current Assets	11.3	66.9	478	347	863
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.015	0.216	0.154	0.101	0.673
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11.3	68	478	347	865
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.6	11.2	36.1	49.9	107
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.6	11.4	48.4	58.7	107
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-4.37	56.6	430	288	758
Total Liabilities & Shareholders' Equity	11.3	68	478	347	865
Total Common Shares Outstanding